Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered
![](./upload/news/image_1611419698_40956190.jpg)
A new study by US-based researchers shows the presence of protective antibodies that target the N-terminal domain (NTD) of the spike instead of the spike receptor-binding domain (RBD).